Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Sheldon H. Preskorn, MD

    Article

    National Initiative to Prevent Suicide: A new proposal to improve the understanding and prevention of suicide

    Author:
    Sheldon H. Preskorn, MD

    Analyzing biological samples from suicide victims could yield valuable data for researchers Suicide is a staggering, tragic, and growing cause of...

    • Read More

    News

    Genetic and related laboratory tests in psychiatry: What mental health practitioners need to know

    Author:
    Sheldon H. Preskorn, MD

    There has been a significant upsurge in the development of new laboratory tests for use in psych­iatric practice. In this Editorial, I answer...

    • Read More

    News

    Protect against drug-drug interactions with anxiolytics

    Author:
    Mohamed I. Ramadan, MD
    Steve F. Werder, DO
    Sheldon H. Preskorn, MD

    Safe use of benzodiazepines, buspirone, and propranolol.

    • Read More

    News

    Drug-drug interactions: Avoid serious adverse events with mood stabilizers

    Author:
    Mohamed Ibrahim Ramadan, MD
    Steven F. Werder, DO
    Sheldon H. Preskorn, MD

    In clinical practice, prescribed drug combinations are often uncontrolled experiments, with unknown potential for toxic effects.

    • Read More

    News

    Something in the air

    Author:
    Ahsan Y. Khan, MD
    Sheldon H. Preskorn, MD
    Inna D’empaire, MD

    Mrs. A, age 64, has persistent depressive and physical symptoms that worsen in winter. In December, she reports that her symptoms have suddenly...

    • Read More

    News

    Commentary: Why patients may not respond to usual recommended dosages

    Author:
    Sheldon H. Preskorn, MD

    3 variables to consider when prescribing antipsychotics

    • Read More

    News

    Managing polypharmacy: Walking the fine line between help and harm

    Author:
    Steven F. Werder, DO
    Sheldon H. Preskorn, MD

    Drug combinations often represent ‘uncontrolled experiments,’ with unknown potential for toxic effects. Yet, combination therapies often are used...

    • Read More

    News

    Managing polypharmacy: Walking the fine line between help and harm

    Author:
    Steven F. Werder, DO
    Sheldon H. Preskorn, MD

    Drug combinations often represent ‘uncontrolled experiments,’ with unknown potential for toxic effects. Yet, combination therapies often are used...

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery